Mitochondrial dysfunction and cancer metabolites and beyond - - PowerPoint PPT Presentation

mitochondrial dysfunction and cancer metabolites and
SMART_READER_LITE
LIVE PREVIEW

Mitochondrial dysfunction and cancer metabolites and beyond - - PowerPoint PPT Presentation

Mitochondrial dysfunction and cancer metabolites and beyond Christian Frezza MRC Cancer Unit, University of Cambridge, Cambridge, UK Corresponding author: cf366@MRC-CU.cam.ac.uk 1 OXPHOS suppression Cancer EMT Metastasis EMT mTUNE


slide-1
SLIDE 1

Mitochondrial dysfunction and cancer metabolites and beyond

Christian Frezza

MRC Cancer Unit, University of Cambridge, Cambridge, UK

Corresponding author: cf366@MRC-CU.cam.ac.uk

1

slide-2
SLIDE 2

Cancer OXPHOS suppression

EMT

Metastasis

slide-3
SLIDE 3

EMT

mTUNE Edoardo Gaude

slide-4
SLIDE 4

A model of primary mitochondrial dysfunction

Neuropathy, ataxia and retinitis pigmentosa (NARP) syndrome

slide-5
SLIDE 5

Heteroplasmy shift using mtZFN

mutant mtDNA wt mtDNA

Michal Minczuk & Payam Gammage Mitochondrial Biology Unit, Cambridge, UK Heteroplasmy shift

slide-6
SLIDE 6

Tunable heteroplasmy shift

Michal Minczuk Payam Gammage

slide-7
SLIDE 7

mTune: a model of tunable mitochondrial dysfunction

mutant mtDNA wt mtDNA 143B osteosarcoma

slide-8
SLIDE 8

mTune: a model of tunable mitochondrial dysfunction

mutant mtDNA wt mtDNA

slide-9
SLIDE 9

mTune: a model of tunable mitochondrial dysfunction

mutant mtDNA wt mtDNA

mTUNE: Stable over time Do not undergo selection

slide-10
SLIDE 10

Metabolic defects in mTune

slide-11
SLIDE 11

mTune and cytoskeleton remodeling

Proteomics mT80 vs mT7

1 2 3 4

G O _ PO S I T I V E _ R E G U LA T I O N _ O F _ A CT I N _ N U CLE A T I O N G O _ CE LL_ PR O JE CT I O N _ O R G A N I Z A T I O N G O _ R E G U LA T I O N _ O F _ A CT I N _ N U CLE A T I O N G O _ LA M E LLI PO D I U M _ O R G A N I Z A T I O N G O _ PO S I T I V E _ R E G U LA T I O N _ O F _ CY T O S KE LE T O N _ O R G A N I Z A T I O N G O _ PO S I T I V E _ R E G U LA T I O N _ O F _ A CT I N _ F I LA M E N T _ PO LY M E R I Z A T I O N G O _ A CT I N _ N U CLE A T I O N G O _ A R P2 _ 3 _ CO M PLE X_ M E D I A T E D _ A CT I N _ N U CLE A T I O N

  • lo g 1 0 p -v a lu e

FDR 0.05

In collaboration with Julio Saez Rodriguez and Aurelien Dugourd, University of Heidelberg

slide-12
SLIDE 12

mTune in wound healing assay

slide-13
SLIDE 13

Migration speed in mTune

m T 7 m T 8 . 0 . 2 . 4 . 6 . 8

v e l o c i t y µ m / m i n * * * *

Sarah Palmer, Norman Lab, Beatson Institute, Glasgow

slide-14
SLIDE 14

GLYCOLYSIS

MITOCHONDRIA

Glycolysis supports cell migration

ATP migration

slide-15
SLIDE 15

Metabolic modelling of mTune

mt7 mt80

METABOLIC MODELLING

ATP production

slide-16
SLIDE 16

Metabolic models of mT7 and mt80

mt7 mt80

slide-17
SLIDE 17

GLYCOLYSIS

Glycolysis is increased in mT80

slide-18
SLIDE 18

Reductive carboxylation of glutamine

Reductive carboxylation

slide-19
SLIDE 19

Reductive carboxylation in mTune

AcCoA Oxaloacetate

slide-20
SLIDE 20

Reductive carboxylation occurs in the cytosol

mT80

AcCoA

  • xaloacetate
slide-21
SLIDE 21

MDH1 links reductive carboxylation to glycolysis

Contribution to ATP production

slide-22
SLIDE 22

MDH1 recycles NADH for glycolytic GAPDH

slide-23
SLIDE 23

MDH1 and glycolysis

slide-24
SLIDE 24

MDH1 and glycolysis

s h N T C s h M D H 1 # 1 s h M D H 1 # 2 0 .0 0 0 .0 1 0 .0 2 0 .0 3 0 .0 4

n o rm a lis e d in te n s ity

M+3 lactate

slide-25
SLIDE 25

??? migration

MDH1 and migration

slide-26
SLIDE 26

MDH1 supports cell migration

slide-27
SLIDE 27

migration

slide-28
SLIDE 28

migration

For more details check Gaude et al, Mol Cell 2018 Follow us at Twitter: @FrezzaLab